RESUMEN
OBJECTIVE: Evaluate the influence of maternal consumption of safflower oil on reflex maturation, memory and offspring hippocampal oxidative stress. METHODOLOGY: Two groups were formed: control group (C), whose mothers received a standard diet, and Safflower group (SF), whose mothers received a normolipidic diet with safflower oil as lipid source. Treatment was given from the 14th day of gestation and throughout lactation. To evaluate newborn development, the reflex ontogeny indicators between the 1st and the 21st days of life were evaluated; to assess memory, from the 42nd day of life on these animals were examined on open field habituation and novel object recognition test. Following behavioral analysis, the animals were anesthetized and decapitated. Hippocampus was rapidly dissected. In the hippocampal tissues, we evaluated the levels of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione S transferase (GST) and reduced glutathione (GSH). RESULTS: SF offspring showed delayed maturation of reflexes and improvement of novel object recognition in short-term and long-term (p < 0.05). Safflower oil decreases lipid peroxidation evaluated by MDA levels (p < 0.001) and increases antioxidant defenses as shown by SOD, CAT, GST and GSH levels (p < 0.05). In our study, the composition of flavonoids present in the oil was not evaluated. Furthermore, in a future study, the effect of maternal consumption on female offspring should be verified. CONCLUSION: Maternal intake of safflower oil could: (1) change neonate reflex parameters, (2) promote improvement of cognitive development in adolescence (3) improve antioxidant enzymatic and non-enzymatic defenses in the hippocampus.
Asunto(s)
Antioxidantes , Efectos Tardíos de la Exposición Prenatal , Animales , Antioxidantes/farmacología , Catalasa/farmacología , Femenino , Flavonoides/farmacología , Glutatión/metabolismo , Glutatión Transferasa/metabolismo , Glutatión Transferasa/farmacología , Hipocampo/metabolismo , Humanos , Lactancia , Malondialdehído , Estrés Oxidativo , Embarazo , Ratas , Ratas Wistar , Reflejo , Aceite de Cártamo/farmacología , Superóxido DismutasaRESUMEN
Diuron herbicide is widely used for weeds control in many kinds of cultivations. It reaches the waterbodies through various fate routes and can adversely threaten non-target organism. The current study was carried out to evaluate the antioxidant activity of Spirulina as feed additive against the toxicity of Diuron concentrations (40 and 80 µg/L) on the edible mollusk Mytilus galloprovincialis during seven days of exposure. Oxidative stress biomarkers were applied on mussel gills and digestive gland, investigating changes in enzymes activities such as catalase (CAT), Glutathione-S-transferase (GST) and Acetylcholinesterase (AChE) and the Malondialdehyde level (MDA). The obtained results show that diuron altered oxidative stress biomarkers in both organs, gills and digestive gland. Performed principle component analysis (PCA) highlighted relationship between biomarkers involved in functional response. Spirulina platensis supplemented diet (1 mg/L), completely ameliorated diuron-induced oxidative stress in mussel tissues. Thus, Spirulina seems to be a promising microalgae and eco-friendly tool helping the health recovery of aquatic animals subjected to environmental stressors.
This study provided recent and new data on the impact of Diuron in marine bivalve and the protective effect of Spirulina against Diuron-induced oxidative stress. The results of our study suggest that the antioxidant potential of Spirulina should be strongly candidate for the phytoremediation of Diuron-aquatic contaminated.
Asunto(s)
Mytilus , Spirulina , Contaminantes Químicos del Agua , Acetilcolinesterasa/metabolismo , Acetilcolinesterasa/farmacología , Animales , Biodegradación Ambiental , Biomarcadores/metabolismo , Diurona/farmacología , Glutatión Transferasa/metabolismo , Glutatión Transferasa/farmacología , Mytilus/metabolismo , Estrés Oxidativo , Spirulina/metabolismo , Contaminantes Químicos del Agua/toxicidadRESUMEN
Curcumin, a polyphenolic antioxidant derived from a dietary spice, exhibits anticancer activity in rodents and in humans. Its efficacy appears to be related to induction of glutathione S-transferase enzymes, inhibition of prostaglandin E(2) (PGE(2)) production, or suppression of oxidative DNA adduct (M(1)G) formation. We designed a dose-escalation study to explore the pharmacology of curcumin in humans. Fifteen patients with advanced colorectal cancer refractory to standard chemotherapies consumed capsules compatible with curcumin doses between 0.45 and 3.6 g daily for up to 4 months. Levels of curcumin and its metabolites in plasma, urine, and feces were analyzed by high-pressure liquid chromatography and mass spectrometry. Three biomarkers of the potential activity of curcumin were translated from preclinical models and measured in patient blood leukocytes: glutathione S-transferase activity, levels of M(1)G, and PGE(2) production induced ex vivo. Dose-limiting toxicity was not observed. Curcumin and its glucuronide and sulfate metabolites were detected in plasma in the 10 nmol/L range and in urine. A daily dose of 3.6 g curcumin engendered 62% and 57% decreases in inducible PGE(2) production in blood samples taken 1 hour after dose on days 1 and 29, respectively, of treatment compared with levels observed immediately predose (P < 0.05). A daily oral dose of 3.6 g of curcumin is advocated for Phase II evaluation in the prevention or treatment of cancers outside the gastrointestinal tract. PGE(2) production in blood and target tissue may indicate biological activity. Levels of curcumin and its metabolites in the urine can be used to assess general compliance.
Asunto(s)
Antineoplásicos/uso terapéutico , Biomarcadores/sangre , Neoplasias Colorrectales/tratamiento farmacológico , Curcumina/uso terapéutico , Cooperación del Paciente , Administración Oral , Anciano , Antineoplásicos/administración & dosificación , Antineoplásicos/farmacocinética , Antineoplásicos/farmacología , Curcumina/administración & dosificación , Curcumina/farmacocinética , Curcumina/farmacología , Dinoprostona/sangre , Femenino , Glutatión Transferasa/farmacología , Humanos , Masculino , Persona de Mediana EdadRESUMEN
The modifying effects of dietary feeding of extract of leaves of ginkgo (Ginkgo biloba) (EGb) and bilobalide isolated from EGb on the development of azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) were investigated in male F344 rats. We also assessed the effects of EGb and bilobalide on proliferating cell nuclear antigen (PCNA) index in 'normal-appearing' crypts and activities of detoxifying enzymes of cytochrome P450 (CYP), glutathione S-transferase (GST) and quinine reductase (QR) activity in the liver. To induce ACF, rats were given two weekly subcutaneous injections of AOM (20 mg/kg body wt). They also received the experimental diets containing EGb (50 or 500 ppm) and bilobalide (15 or 150 ppm) for 4 weeks, starting 1 week before the first dosing of AOM. AOM exposure produced a substantial number of ACF (106 +/- 10) at the end of the study (week 4). Dietary administration of EGb and bilobalide caused significant reduction in the frequency of ACF: 50 ppm EGb, 73 +/- 17 (31% reduction, P < 0.001); 500 ppm EGb, 56 +/- 13 (47% reduction, P < 0.001); 15 ppm bilobalide, 79 +/- 17 (25% reduction, P < 0.001); and 150 ppm bilobalide, 71 +/- 30 (33% reduction, P < 0.01). Immunohistochemically, EGb or bilobalide administration significantly lowered PCNA index in normal-appearing crypts. Feeding with EGb or bilobalide increased activities of CYP as well as GST and QR in the liver. These findings might suggest possible chemopreventive ability of EGb or bilobalide, through alterations in cryptal cell proliferation activity and drug metabolizing enzymes' activities, in colon tumorigenesis.
Asunto(s)
Neoplasias del Colon/prevención & control , Ciclopentanos/farmacología , Diterpenos/farmacología , Furanos/farmacología , Ginkgo biloba/química , Fitoterapia , Extractos Vegetales/farmacología , Lesiones Precancerosas/prevención & control , Administración Oral , Animales , Azoximetano/administración & dosificación , Azoximetano/toxicidad , Carcinógenos/administración & dosificación , Carcinógenos/toxicidad , Quimioprevención , Neoplasias del Colon/fisiopatología , Neoplasias del Colon/veterinaria , Sistema Enzimático del Citocromo P-450/farmacología , Dieta , Ginkgólidos , Glutatión Transferasa/farmacología , Inmunohistoquímica , Masculino , Hojas de la Planta/química , Lesiones Precancerosas/fisiopatología , Lesiones Precancerosas/veterinaria , Antígeno Nuclear de Célula en Proliferación/análisis , Ratas , Ratas Endogámicas F344RESUMEN
Herb-drug interactions, especially cytochrome P450 (CYP)-mediated interactions, cause an enhancement or attenuation in efficacy of co-administered drugs. In a previous study, we reported that repeated oral ingestion of Ginkgo biloba extract (GBE) markedly induced hepatic drug metabolizing enzymes in rats. In this study, we focused on the recovery of GBE-induced hepatic drug metabolizing enzymes after the discontinuation of GBE in rats. Feeding of a 0.5% GBE diet to rats for 1 week markedly increased liver weight, content of total CYP, activities of 6 CYP subtypes and glutathione S-transferase (GST). The content and activities of CYP enzymes were recovered to almost basal levels within 1 week after the discontinuation of GBE, while the activity of GST gradually decreased and recovered to the control level after 3 weeks. These results indicated that GBE-induced hepatic drug metabolizing enzymes in rats, especially CYPs, were rapidly recovered by discontinuation of GBE in rats even after excess treatment, and suggested that interactions of GBE with drugs could be avoided by discontinuation of GBE.
Asunto(s)
Sistema Enzimático del Citocromo P-450/efectos de los fármacos , Sistema Enzimático del Citocromo P-450/farmacología , Ginkgo biloba/química , Glutatión Transferasa/efectos de los fármacos , Glutatión Transferasa/farmacología , Animales , Interacciones Farmacológicas , Cinética , Hígado/enzimología , Masculino , Extractos Vegetales/farmacología , Ratas , Ratas WistarRESUMEN
Glutathione S-transferase (GST), a member of the phase II group of xenobiotic metabolizing enzymes, has been intensively studied at the levels of phenotype and genotype. The GST mu 1 (GSTM1) and GST theta 1 (GSTT1) genes have a null-allele variant in which the entire gene is absent. The null genotype for both enzymes has been associated with many different types of tumors. The aim of this study was to determine the possible differences in increased oxidative stress susceptibility to smoking within the GSTM1 and GSTT1 genotypes and the impact of high tea drinking on this. We designed a Phase II randomized, controlled, three-arm tea intervention trial to study the effect of high consumption (4 cups/day) of decaffeinated green or black tea, or water on oxidative DNA damage, as measured by urinary 8-hydroxydeoxyguanosine (8-OHdG), among heavy smokers over a 4-month period and to evaluate the roles of GSTM1 and GSTT1 genotypes as effect modifiers. A total of 133 heavy smokers (100 females and 33 males) completed the intervention. GSTM1 and GSTT1 genotype statuses were determined with a PCR-based approach. Multiple linear regression models were used to estimate the main effects and interaction effect of green and black tea consumption on creatinine-adjusted urinary 8-OHdG, with or without adjustment for potential confounders. Finally, we studied whether the effect of treatment varied by GSTM1 and GSTT1 status of the individual. Although there were no differences in urinary 8-OHdG between the groups at baseline, the between-group 8-OHdG levels at month 4 were statistically significant for GSTM1-positive smokers (P = 0.05) and GSTT1-positive smokers (P = 0.02). GSTM1-positive and GSTT1-positive smokers consuming green tea showed a decrease in urinary 8-OHdG levels after 4 months. Assessment of urinary 8-OHdG after adjustment for baseline measurements and other potential confounders revealed significant effect for green tea consumption (P = 0.001). The change from baseline was significant in both GSTM1-positive (t = -2.99; P = 0.006) and GSTT1-positive (P = 0.004) green tea groups, but not in the GSTM1-negative (P = 0.07) or GSTT1-negative (P = 0.909) green tea groups. Decaffeinated black tea consumption had no effect on urinary 8-OHdG levels among heavy smokers. Our data show that consumption of 4 cups of tea/day is a feasible and safe approach and is associated with a significant decrease in urinary 8-OHdG among green tea consumers after 4 months of consumption. This finding also suggests that green tea intervention may be effective in the subgroup of smokers who are GSTM1 and/or GSTT1 positive.
Asunto(s)
Daño del ADN , Predisposición Genética a la Enfermedad , Glutatión Transferasa/genética , Glutatión Transferasa/farmacología , Guanina/análogos & derivados , Guanina/orina , Estrés Oxidativo , Fumar/efectos adversos , Té , 8-Hidroxi-2'-Desoxicoguanosina/análogos & derivados , Administración Oral , Adolescente , Adulto , Anciano , Biomarcadores/análisis , Carcinógenos/metabolismo , Dieta , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , AguaRESUMEN
This study investigated the effects of sulfur dioxide (SO2) inhalation and protection by sea buckthorn seed oil from oxidative damage caused by SO2 in male Kunming-strain mice. One approach was set up to study the effects of SO2 inhalation on changes of the mice antioxidant defense system. SO2 at different concentrations (22 +/- 2, 64 +/- 3, and 148 +/- 23 mg/m3) was administered to animals in treatment groups for 7 days, 6 h per day, while control groups were exposed to filtered air under the same condition. The activities of glutathione-S-transferase (GST) and glucose-6-phosphate dehydrogenase (G6PD) and the contents of reduced glutathione (GSH) in brain, lung, heart, liver, and kidney of mice were measured. In the case of inhalation of a SO2 concentration of 148 +/- 23 mg/m3, the activities of GST and G6PD and contents of GSH in the brain, lung, heart, liver, and kidney were significantly decreased. Dose-dependent relations were found between various SO2-exposed concentrations and the activities of GST and G6PD and the content of GSH. Meanwhile another approach was taken to determine whether sea buckthorn seed oil could maintain the glutathione redox system and prevent the oxidative damage of lung induced by SO2. In groups given a high dosage (6 or 8 ml/kg) intraperitoneally, the level of TBARS (thiobarbituric acid-reactive substances) was decreased significantly (p < 0.05) by the injection of sea buckthorn seed oil, and the activity of GST was increased significantly (p < 0.05). Overall GST activity and TBARS level exhibited a significant negative correlation (r = 0.891, p < 0.05). The observations showed that SO2 inhalation resulted in a significant change in the glutathione redox system and indicated that sea buckthorn seed oil could contribute to the antioxidant effects in the case of SO2 exposure.
Asunto(s)
Contaminantes Atmosféricos/toxicidad , Glucosafosfato Deshidrogenasa/farmacología , Glutatión Transferasa/farmacología , Glutatión/metabolismo , Hippophae/química , Exposición por Inhalación , Dióxido de Azufre/toxicidad , Animales , Masculino , Ratones , Oxidación-Reducción , Estrés Oxidativo , Aceites de Plantas/farmacología , Semillas/química , Dióxido de Azufre/administración & dosificaciónRESUMEN
The anti-tumour and anti-cholesterol impacts of tocotrienol-rich fraction (TRF) were investigated in rats treated with the chemical carcinogen 7,12-dimethylbenz [alpha]anthracene (DMBA), which is known to induce mammary carcinogenesis and hypercholesterolaemia. DMBA administration to rats was associated with the appearance of multiple tumours on mammary glands after 6 months. Alkaline phosphatase (ALP) and glutathione-S-transferase (GST) are used as marker enzymes to monitor the severity of carcinogenesis. Although no tumours were visible on livers, hepatic ALP and GST activities of DMBA-treated rats were profoundly elevated in comparison to enzyme activities of normal control rats. Feeding of TRF (10 mg/kg body weight/day) for 6 months, isolated from rice bran oil (RBO), to DMBA-administered rats, reduced the severity and extent of neoplastic transformation in the mammary glands. Similarly, plasma and mammary ALP activities increased during carcinogenesis (95% and 43%, respectively), were significantly decreased in TRF-treated rats, whereas TRF mediated a further increase of 51% in hepatic ALP activity. TRF treatment to rats maintained low levels of GST activities in liver ( approximately 32%) and mammary glands ( approximately 21%), which is consistent with anti-carcinogenic properties of TRF. Administration of DMBA also caused a significant increase of 30% in plasma total cholesterol and 111% in LDL-cholesterol levels compared with normal control levels. Feeding of TRF to rats caused a significant decline of 30% in total cholesterol and 67% in LDL-cholesterol levels compared with the DMBA-administered rats. The experimental hypercholesterolaemia caused a significant increase in enzymatic activity (23%) and protein mass (28%) of hepatic 3-hydroxy-3-methylglutaryl co-enzyme A (HMG-CoA) reductase. Consistent with TRF-mediated reduction in plasma lipid levels, enzymatic activity and protein mass of HMG-CoA reductase was significantly reduced. These results indicate that TRF has potent anti-cancer and anti-cholesterol effects in rats.
Asunto(s)
9,10-Dimetil-1,2-benzantraceno/farmacología , Antioxidantes/farmacología , Carcinógenos/farmacología , Transformación Celular Neoplásica , Hipercolesterolemia/complicaciones , Aceites de Plantas/química , Tocotrienoles/farmacología , Acilcoenzima A/farmacología , Administración Oral , Fosfatasa Alcalina/farmacología , Animales , Antioxidantes/administración & dosificación , Colesterol/análisis , Femenino , Glutatión Transferasa/farmacología , Hígado/química , Neoplasias Mamarias Animales/diagnóstico , Neoplasias Mamarias Animales/prevención & control , Ratas , Ratas Sprague-Dawley , Aceite de Salvado de Arroz , Tocotrienoles/administración & dosificaciónRESUMEN
Organochalcogens are important intermediates and useful reagents in organic synthesis, which can increase human exposure risk to these chemicals in the workplace. As well, there are a number of reported cases of acute toxicity following organochalcogen ingestion of vitamins and dietary supplements. Since, the erythrocytic delta-ALA-D activity could be an important indicator of toxicity this report investigated the organochalcogens effects on blood delta-ALA-D in vitro. To investigate a possible involvement of cysteinyl groups in the inhibitory actions of diphenyl diselenide, diphenyl ditelluride and Ebselen (4-100 micro M), the effects of thiol reducing agents (0-3 mM) or zinc chloride (0-2 mM) were examined. Diphenyl ditelluride, diphenyl diselenide and Ebselen inhibited in a concentration-dependent manner delta-ALA-D activity from human erythrocytes. Ebselen was lesser delta-ALA-D inhibitor than (PhSe)(2) and (PhTe)(2), whereas the diorganoyldichalcogenides displayed similar inhibitory potency towards delta-ALA-D. Dithiothreitol, a hydrophobic SH-reducing agent, was able to reactivate and to protect inhibited delta-ALA-D. The pre-incubation of blood with the inhibitors changed considerably the reversing potency of thiols. From these findings we suggest that organochalcogens inactivate in vitro human erythrocyte delta-ALA-D by an interaction with the sulfhydryl group essential of the enzyme activity.
Asunto(s)
Antioxidantes/toxicidad , Azoles/toxicidad , Derivados del Benceno/toxicidad , Disulfuros/toxicidad , Eritrocitos/efectos de los fármacos , Compuestos Organometálicos/toxicidad , Compuestos de Organoselenio/toxicidad , Porfobilinógeno Sintasa/metabolismo , Azoles/antagonistas & inhibidores , Azoles/sangre , Derivados del Benceno/antagonistas & inhibidores , Derivados del Benceno/sangre , Cisteína/farmacología , Disulfuros/antagonistas & inhibidores , Disulfuros/sangre , Ditiotreitol/farmacología , Interacciones Farmacológicas , Eritrocitos/enzimología , Glutatión Transferasa/farmacología , Humanos , Isoindoles , Compuestos Organometálicos/antagonistas & inhibidores , Compuestos Organometálicos/sangre , Compuestos de Organoselenio/antagonistas & inhibidores , Compuestos de Organoselenio/sangre , Porfobilinógeno Sintasa/antagonistas & inhibidores , Zinc/farmacologíaRESUMEN
In this study the effects of heavy metals (manganese, iron, copper, zinc) and selenium exposure on the hepatic activity of antioxidant enzymes, superoxide dismutase (SOD) and glutathione S-transferases (GST), were appraised on a seasonal basis in Algerian mice (Mus spretus) inhabiting an active copper mine area. A reference population of the same species was considered for comparative purposes. Different patterns of seasonal variation were found in both populations for the manganese, iron and selenium hepatic concentrations and SOD activity. When the two populations were compared, iron and selenium concentrations were enhanced in mice from the polluted area. In addition, SOD activity was significantly decreased in summer in exposed mice, but no other significant changes in SOD and GST activities between sites throughout the year were recorded. However, when seasonal data within each group of mice were pooled, significant differences were found between sites for the average concentrations of manganese, iron and selenium, which are higher in the polluted site. In addition, significant differences were obtained for the average values of SOD and of GST activities, due to simultaneously higher GST values and slightly lower SOD values in the polluted site. The population from the reference site was more homogeneous for all parameters measured than the population from the polluted area. These results, in particular the higher variability in data collected from mice exposed to heavy metals and selenium, combined with the negative associations between biochemical markers and heavy metals, may suggest, despite the good adaptability of the mice to their habitat, biochemical stress due to diminished environmental quality.
Asunto(s)
Glutatión Transferasa/análisis , Hígado/química , Metales Pesados/efectos adversos , Ratones , Selenio/efectos adversos , Superóxido Dismutasa/análisis , Animales , Cobre , Femenino , Glutatión Transferasa/farmacología , Hígado/enzimología , Masculino , Minería , Portugal , Reproducibilidad de los Resultados , Superóxido Dismutasa/farmacologíaRESUMEN
The activity of human cytosolic glutathione S-transferases (GSTs) can positively or negatively be changed by various compounds. It is for instance known that RRR-alpha-tocopherol inhibits GST P1-1 [Haaften van R.I.M. et al. (2001) Alpha-tocopherol inhibits human glutathione S-transferase pi. BBRC 280, 631-633]. The effect of RRR-alpha-tocopherol on the other isoenzymes of GST in purified forms of the isoenzymes and in human liver cytosol (GST M and GST A) and lysate of human erythrocytes (GST P) is studied. It is found that all isoenzymes (purified enzymes and enzymes present in homogenates) are inhibited, in a concentration-dependent way, by RRR-alpha-tocopherol. GST P is in both cases inhibited with the highest potency compared to the other isoenzymes. It also appeared that the purified GST P1-1 isoenzyme is non-competitively inhibited by RRR-alpha-tocopherol. The IC(50) values of RRR-alpha-tocopherol for the purified isoenzymes of GST are much lower compared to the IC(50) values for human lysate and human liver cytosol. This is probably due to binding of RRR-alpha-tocopherol to proteins, e.g. albumin and hemoglobin, with higher affinity than to GST; so more RRR-alpha-tocopherol is needed to inhibit the enzyme. However, the inhibition of GSTs by RRR-alpha-tocopherol can still be of physiological relevance, because due to dermal application of cosmetic products very high concentrations vitamin E can be reached in the skin, where GST P1-1 is present. RRR-alpha-tocopherol might also be a good lead compound for the development of a new class of inhibitors of GST that can be used as adjuvant in cancer therapy.
Asunto(s)
Antioxidantes/farmacología , Glutatión Transferasa/antagonistas & inhibidores , alfa-Tocoferol/farmacología , Adulto , Eritrocitos/enzimología , Femenino , Glutatión Transferasa/farmacología , Humanos , Técnicas In Vitro , Isoenzimas , Hígado/enzimologíaRESUMEN
The presence of cyanobacterial toxins in drinking and recreational waters represents a potential public health risk. Microcystin-LR (MC-LR) is a potent cyclic heptapeptide hepatotoxin produced by the blue-green alga Microcystis aeruginosa. Chemoprotectant studies have indicated that membrane-active antioxidants such as vitamin E may offer protection against microcystin toxicity. This study investigated the effect of vitamin E supplementation on microcystin toxicity in mouse liver. Groups of mice were fed vitamin E supplements (8.33 or 33.3 U/mouse/day) for 4 weeks, with intraperitoneal doses of MC-LR extract (70% LD(50)) every 3 days from day 8. The potential benefits of vitamin E were evaluated based on lipid peroxidation, alanine transaminase (ALT), and glutathione S-transferase (GST) levels. Vitamin E supplementation at 33.3 U/mouse/day offered some protection against lipid peroxidation induced by repeated exposure to MC-LR extract and limited both the toxin-induced increase in ALT leakage and decrease in GST activity. Vitamin E supplementation at 66.6 U/mouse/day significantly increased the time to death and reduced the increase in liver percentage body weight induced in mice given a lethal dose challenge of MC-LR extract. Therefore, vitamin E, taken as a dietary supplement, may have a protective effect against chronic exposure to MC-LR.
Asunto(s)
Cianobacterias/patogenicidad , Péptidos Cíclicos/toxicidad , Vitamina E/farmacología , Abastecimiento de Agua , Animales , Toxinas Bacterianas/toxicidad , Glutatión Transferasa/farmacología , Infusiones Parenterales , Peroxidación de Lípido , Hígado/patología , Masculino , Toxinas Marinas/toxicidad , Ratones , Ratones Endogámicos BALB C , Microcistinas , Salud Pública , RecreaciónRESUMEN
Inhibitors and their mechanisms of inhibition of various processes in chemical carcinogenesis, metabolic activation of chemical carcinogens followed by initiation and promotion in chemical carcinogenesis are reviewed. Furthermore, significance of the inhibitors of chemical carcinogenesis in foods and food additives and problems of side effects of these inhibitors are discussed.